Zenotech Laboratories Submits Q4FY26 Compliance Certificate Under SEBI Regulations
Zenotech Laboratories Limited submitted its compliance certificate under SEBI Regulation 74(5) for Q4FY26 quarter ended March 31, 2026. The certificate from KFin Technologies Limited confirms proper processing of securities dematerialization, with all regulatory requirements met including timely substitution of depository names in member registers. Company Secretary Abdul Gafoor Mohammad filed the documentation on April 07, 2026, maintaining the company's regulatory compliance standards.
*this image is generated using AI for illustrative purposes only.
Zenotech Laboratories Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The pharmaceutical company submitted the mandatory documentation for the quarter ended March 31, 2026, demonstrating adherence to securities dematerialization protocols.
Regulatory Compliance Filing
The compliance certificate was submitted on April 07, 2026, pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The certificate, dated April 06, 2026, was issued by KFin Technologies Limited, which serves as the company's Registrar & Share Transfer Agent.
| Filing Details: | Information |
|---|---|
| Quarter Ended: | March 31, 2026 |
| Certificate Date: | April 06, 2026 |
| Submission Date: | April 07, 2026 |
| Registrar: | KFin Technologies Limited |
| Scrip Code: | 532039 |
Certificate Confirmation
KFin Technologies Limited confirmed that all securities received from depository participants for dematerialization during the quarter ended March 31, 2026 were properly processed. The registrar verified that:
- Securities received for dematerialization were confirmed to depositories
- All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
- Security certificates received for dematerialization were mutilated and cancelled after due verification
- Depository names were substituted in the register of members as registered owners within 15 days
Company Leadership
The compliance certificate was signed by Abdul Gafoor Mohammad, Company Secretary & Compliance Officer of Zenotech Laboratories Limited. Mohammad holds ICSI Membership No. A22331 and digitally signed the document on April 07, 2026.
Corporate Information
Zenotech Laboratories Limited operates from its registered office and factory located at Survey No. 250-252, Turkapally Village, Genome Valley Road, Shamirpet Mandal, Medchal-Malkajgiri District, Hyderabad. The company maintains its corporate identification number as L27100TG1989PLC010122, reflecting its incorporation in Telangana in 1989.
The quarterly compliance filing represents standard regulatory practice, ensuring transparency in securities handling and maintaining investor confidence through proper documentation of dematerialization processes.
Historical Stock Returns for Zenotech Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -100.00% | -2.35% | +29.34% | -5.65% | -23.08% | +2.63% |
What strategic initiatives might Zenotech Laboratories pursue in FY2027 following their consistent regulatory compliance track record?
How could potential changes to SEBI's dematerialization regulations impact pharmaceutical companies like Zenotech in the coming quarters?
Will Zenotech Laboratories consider expanding their manufacturing capacity beyond their current Hyderabad facility given their operational stability?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
